SCHEMBL6583550

SCHEMBL6583550

CC(NC1CC1)c1cccnc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
KDM4E B2RXH2 1/20 0.56
CFTR P13569 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
GOPC Q9HD26 1/20 0.44
TSHR P16473 2/20 0.43
MAPT P10636 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP1A2 P05177 1/20 0.40
ALDH1A1 P00352 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10983034 0.92 GAA (0.65) GAAL3MBTL1KDM4ETSHRSMN1; SMN2
SCHEMBL8012590 0.79 KDM4E (0.65) GAAL3MBTL1KDM4ECFTRSLC6A2
SCHEMBL664938 0.79 GAA (0.85) GAAL3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL27818229 0.79 GAA (0.85) GAAL3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL28900208 0.79 KDM4E (0.46) GAAL3MBTL1KDM4ETSHRMAPT
SCHEMBL13081367 0.77 KDM4E (0.62) GAAL3MBTL1KDM4ECFTRSLC6A2
SCHEMBL2373412 0.77 KDM4E (0.62) GAAL3MBTL1KDM4ECFTRSLC6A2
SCHEMBL6220536 0.76 KDM4E (0.61) GAAL3MBTL1KDM4ECFTRSLC6A2
SCHEMBL1487951 0.76 KDM4E (0.61) GAAL3MBTL1KDM4ECFTRSLC6A2
SCHEMBL6583342 0.76 KDM4E (0.61) GAAL3MBTL1KDM4ECFTRSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0871615-B1 SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS MERCK & CO INC (US) 2004-07-14 EP disclosed
US-6194581-B1 FOR TREATMENT OF DYSFUNCTION OF THE CENTRAL OR AUTONOMIC NERVOUS SYSTEMS INCLUDING DEMENTIA, COGNITIVE DISORDERS, NEURODEGENERATIVE DISORDERS, EXTRAPYRAMIDAL DISORDERS, CONVULSIVE DISORDERS, CARDIOVASCULAR DISORDERS, PAIN MERCK & CO., INC. 2001-02-27 US disclosed
US-5852041-A Substituted pyridines useful as modulators of acethylcholine receptors SIBIA NEUROSCIENCES, INC. (US) 1998-12-22 US disclosed
EP-0871615-A1 SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS SIBIA NEUROSCIENCES, INC. (US) 1998-10-21 EP disclosed
US-5736560-A USEFUL IN THE TREATMENT OF ALZHEIMER'S AND PARKINSONS'S DISEASES SIBIA NEUROSCIENCES, INC. (US) 1998-04-07 US disclosed
US-5686473-A TREATING PARKINSON*S DISEASE, ALZHEIMER*S DISEASE, DEMENTIA AND PAIN SIBIA NEUROSCIENCES, INC. (US) 1997-11-11 US disclosed
US-5585388-A Substituted pyridines useful as modulators of acetylcholine receptors SIBIA NEUROSCIENCES, INC. (US) 1996-12-17 US disclosed
WO-1996031475-A2 SUBSTITUTED PYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MODULATORS OF ACETYLCHOLINE RECEPTORS SIBIA NEUROSCIENCES, INC. (US) 1996-10-10 WO disclosed